<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
  xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
  xmlns:image="http://www.google.com/schemas/sitemap-image/1.1">
  <url>
    <loc>https://researchpepnews.com/articles/glp1-drugs-male-fertility-sperm-count</loc>
    <news:news>
      <news:publication>
        <news:name>Research Pep News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-06</news:publication_date>
      <news:title>GLP-1 Drugs and Male Fertility: Can Weight Loss Improve Sperm Count and Testosterone?</news:title>
    </news:news>
    <image:image>
      <image:loc>https://researchpepnews.com/images/editorial/tirzepatide-male-fertility-sperm-count.jpg</image:loc>
      <image:caption>Large, sustained weight loss may relieve several forms of metabolic pressure on male reproductive function. Waist change is one visible marker of that broader shift. Photo by Karolina Grabowska/Kaboompics via Pexels.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://researchpepnews.com/articles/oral-bpc157-peptide-bioregulators-bioavailability</loc>
    <news:news>
      <news:publication>
        <news:name>Research Pep News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-05</news:publication_date>
      <news:title>The Oral-Peptide Paradox: Why BPC-157 May Be an Exception</news:title>
    </news:news>
    <image:image>
      <image:loc>https://researchpepnews.com/images/editorial/oral-bpc157-peptide-bioregulators.png</image:loc>
      <image:caption>An oral peptide claim is a chain, not a single fact. Gastric survival matters, but so do intestinal stability, access to the target and a measurable biological effect. Image: Research Pep News.</image:caption>
    </image:image>
  </url>
</urlset>